Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study.

Klopstock T, Tricta F, Neumayr L, Karin I, Zorzi G, Fradette C, Kmieć T, Büchner B, Steele HE, Horvath R, Chinnery PF, Basu A, Küpper C, Neuhofer C, Kálmán B, Dušek P, Yapici Z, Wilson I, Zhao F, Zibordi F, Nardocci N, Aguilar C, Hayflick SJ, Spino M, Blamire AM, Hogarth P, Vichinsky E.

Lancet Neurol. 2019 Jul;18(7):631-642. doi: 10.1016/S1474-4422(19)30142-5.

PMID:
31202468
2.

Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.

Hoppe C, Neumayr L.

Hematol Oncol Clin North Am. 2019 Jun;33(3):355-371. doi: 10.1016/j.hoc.2019.01.014. Epub 2019 Mar 28. Review.

PMID:
31030807
3.

Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial).

Daak AA, Dampier CD, Fuh B, Kanter J, Alvarez OA, Black LV, McNaull MA, Callaghan MU, George A, Neumayr L, Hilliard LM, Sancilio F, Rabinowicz AL, Heeney MM.

Blood Adv. 2018 Aug 14;2(15):1969-1979. doi: 10.1182/bloodadvances.2018021444.

4.

A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP; Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease.

N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971.

5.

Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience.

Winstead M, Sun PP, Martin K, Earl J, Neumayr L, Hoppe C, Vichinsky E.

Pediatr Hematol Oncol. 2017 Mar;34(2):100-106. doi: 10.1080/08880018.2017.1313917. Epub 2017 May 22.

PMID:
28532265
6.

Emergency department utilization by Californians with sickle cell disease, 2005-2014.

Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26390. Epub 2016 Dec 21.

7.

Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.

Dowling MM, Quinn CT, Ramaciotti C, Kanter J, Osunkwo I, Inusa B, Iyer R, Kwiatkowski JL, Johnson C, Rhodes M, Owen W, Strouse JJ, Panepinto JA, Neumayr L, Sarnaik S, Plumb PA, Dlamini N, Kirkham F, Hynan LS; PFAST Investigators.

Br J Haematol. 2017 Jan;176(2):300-308. doi: 10.1111/bjh.14391. Epub 2016 Oct 21.

8.

Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literature.

Kelly S, Quirolo K, Marsh A, Neumayr L, Garcia A, Custer B.

Transfusion. 2016 Nov;56(11):2877-2888. doi: 10.1111/trf.13800. Epub 2016 Oct 19. Review.

PMID:
27759170
9.

Stroke recurrence in adult sickle cell patients: it is time for action!

Neumayr L, Vichinsky E.

Transfusion. 2016 May;56(5):1001-4. doi: 10.1111/trf.13614. No abstract available.

PMID:
27167352
10.

Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients.

Porter JB, Walter PB, Neumayr LD, Evans P, Bansal S, Garbowski M, Weyhmiller MG, Harmatz PR, Wood JC, Miller JL, Byrnes C, Weiss G, Seifert M, Grosse R, Grabowski D, Schmidt A, Fischer R, Nielsen P, Niemeyer C, Vichinsky E.

Br J Haematol. 2014 Dec;167(5):692-6. doi: 10.1111/bjh.13081. Epub 2014 Sep 11.

11.

Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH).

Paulukonis ST, Harris WT, Coates TD, Neumayr L, Treadwell M, Vichinsky E, Feuchtbaum LB.

Pediatr Blood Cancer. 2014 Dec;61(12):2271-6. doi: 10.1002/pbc.25208. Epub 2014 Aug 30.

PMID:
25176145
12.

Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition.

Mackin RS, Insel P, Truran D, Vichinsky EP, Neumayr LD, Armstrong FD, Gold JI, Kesler K, Brewer J, Weiner MW; Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group.

Neurology. 2014 Mar 11;82(10):835-41. doi: 10.1212/WNL.0000000000000188. Epub 2014 Feb 12.

13.

Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).

Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, Boudreaux J, Neufeld EJ, Kenney K, Grant A, Thompson AA; CDC Thalassemia Investigators.

Transfusion. 2014 Apr;54(4):972-81; quiz 971. doi: 10.1111/trf.12348. Epub 2013 Jul 25.

14.

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

Haematologica. 2013 Sep;98(9):1375-82. doi: 10.3324/haematol.2013.086637. Epub 2013 May 3.

15.

Combined chelation therapy with deferasirox and deferoxamine in thalassemia.

Lal A, Porter J, Sweeters N, Ng V, Evans P, Neumayr L, Kurio G, Harmatz P, Vichinsky E.

Blood Cells Mol Dis. 2013 Feb;50(2):99-104. doi: 10.1016/j.bcmd.2012.10.006. Epub 2012 Nov 11.

16.

A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease.

Kutlar A, Ataga K, Reid M, Vichinsky EP, Neumayr L, Blair-Britt L, Labotka R, Glass J, Keefer JR, Wargin WA, Berenson R, Perrine SP.

Am J Hematol. 2012 Nov;87(11):1017-21. doi: 10.1002/ajh.23306. Epub 2012 Aug 7.

17.

Lip cancer: retrospective analysis of 181 cases.

Géraud C, Koenen W, Neumayr L, Doobe G, Schmieder A, Weiss C, Goerdt S, Faulhaber J.

J Dtsch Dermatol Ges. 2012 Feb;10(2):121-7. doi: 10.1111/j.1610-0387.2011.07853.x. Epub 2011 Dec 2.

PMID:
22136191
18.

Red blood cell transfusion in pediatric patients with severe chronic anemia: how slow is necessary?

Agrawal AK, Hsu E, Quirolo K, Neumayr LD, Flori HR.

Pediatr Blood Cancer. 2012 Mar;58(3):466-8. doi: 10.1002/pbc.23238. Epub 2011 Jul 25.

PMID:
21793178
19.

Improved engraftment with minimal graft-versus-host disease after major histocompatibility complex-mismatched cord blood transplantation with photochemically treated donor lymphocytes.

Kanathezhath B, Mizokami M, Stanislaus S, Hounshell C, Neumayr L, Guo H, Hearst JE, Walters MC, Kuypers FA.

Exp Biol Med (Maywood). 2011 Apr 1;236(4):492-504. doi: 10.1258/ebm.2011.010216. Epub 2011 Mar 31.

PMID:
21454375
20.

The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial.

Wang W, Brugnara C, Snyder C, Wynn L, Rogers Z, Kalinyak K, Brown C, Qureshi A, Bigelow C, Neumayr L, Smith-Whitley K, Chui DH, Delahunty M, Woolson R, Steinberg M, Telen M, Kesler K.

Br J Haematol. 2011 Mar;152(6):771-6. doi: 10.1111/j.1365-2141.2010.08523.x. Epub 2011 Jan 31.

PMID:
21275961
21.

Chart Card: feasibility of a tool for improving emergency department care in sickle cell disease.

Neumayr L, Pringle S, Giles S, Quirolo KC, Paulukonis S, Vichinsky EP, Treadwell MJ.

J Natl Med Assoc. 2010 Nov;102(11):1017-23.

22.

Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia.

Vichinsky EP, Neumayr LD, Gold JI, Weiner MW, Rule RR, Truran D, Kasten J, Eggleston B, Kesler K, McMahon L, Orringer EP, Harrington T, Kalinyak K, De Castro LM, Kutlar A, Rutherford CJ, Johnson C, Bessman JD, Jordan LB, Armstrong FD; Neuropsychological Dysfunction and Neuroimaging Adult Sickle Cell Anemia Study Group.

JAMA. 2010 May 12;303(18):1823-31. doi: 10.1001/jama.2010.562.

23.

Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia.

Fung EB, Harmatz PR, Milet M, Coates TD, Thompson AA, Ranalli M, Mignaca R, Scher C, Giardina P, Robertson S, Neumayr L, Vichinsky EP; Multi-Center Iron Overload Study Group.

Bone. 2008 Jul;43(1):162-168. doi: 10.1016/j.bone.2008.03.003. Epub 2008 Mar 15.

24.

Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment.

Neumayr LD, Aguilar C, Earles AN, Jergesen HE, Haberkern CM, Kammen BF, Nancarrow PA, Padua E, Milet M, Stulberg BN, Williams RA, Orringer EP, Graber N, Robertson SM, Vichinsky EP; National Osteonecrosis Trial in Sickle Cell Anemia Study Group.

J Bone Joint Surg Am. 2006 Dec;88(12):2573-82.

PMID:
17142406
25.

Bone and joint disease in sickle cell disease.

Aguilar C, Vichinsky E, Neumayr L.

Hematol Oncol Clin North Am. 2005 Oct;19(5):929-41, viii. Review.

PMID:
16214653
26.

Clinical evaluation of avascular necrosis in patients with sickle cell disease: Children's Hospital Oakland Hip Evaluation Scale--a modification of the Harris Hip Score.

Aguilar CM, Neumayr LD, Eggleston BE, Earles AN, Robertson SM, Jergesen HE, Stulberg BN, Vichinsky EP.

Arch Phys Med Rehabil. 2005 Jul;86(7):1369-75.

PMID:
16003666
27.

Mycoplasma disease and acute chest syndrome in sickle cell disease.

Neumayr L, Lennette E, Kelly D, Earles A, Embury S, Groncy P, Grossi M, Grover R, McMahon L, Swerdlow P, Waldron P, Vichinsky E.

Pediatrics. 2003 Jul;112(1 Pt 1):87-95.

PMID:
12837872
28.

Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease.

Dean D, Neumayr L, Kelly DM, Ballas SK, Kleman K, Robertson S, Iyer RV, Ware RE, Koshy M, Rackoff WR, Pegelow CH, Waldron P, Benjamin L, Vichinsky E; Acute Chest Syndrome Study Group.

J Pediatr Hematol Oncol. 2003 Jan;25(1):46-55.

PMID:
12544773
29.

Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.

Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, Golden D, Neumayr L, Vichinsky E.

Blood. 2000 Jul 1;96(1):76-9.

PMID:
10891433
30.

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

N Engl J Med. 2000 Jun 22;342(25):1855-65. Erratum in: N Engl J Med 2000 Sep 14;343(11):824.

31.

The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group.

Vichinsky EP, Neumayr LD, Haberkern C, Earles AN, Eckman J, Koshy M, Black DM.

Am J Hematol. 1999 Nov;62(3):129-38.

32.

Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. Preoperative Transfusion in Sickle Cell Disease Study Group.

Waldron P, Pegelow C, Neumayr L, Haberkern C, Earles A, Wesman R, Vichinsky E.

J Pediatr Hematol Oncol. 1999 Mar-Apr;21(2):129-35.

PMID:
10206459
33.

Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group.

Neumayr L, Koshy M, Haberkern C, Earles AN, Bellevue R, Hassell K, Miller S, Black D, Vichinsky E.

Am J Hematol. 1998 Feb;57(2):101-8.

34.

Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group.

Haberkern CM, Neumayr LD, Orringer EP, Earles AN, Robertson SM, Black D, Abboud MR, Koshy M, Idowu O, Vichinsky EP.

Blood. 1997 Mar 1;89(5):1533-42.

PMID:
9057634
35.

A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.

Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, Abboud M, Ohene-Frempong K, Iyer RV.

N Engl J Med. 1995 Jul 27;333(4):206-13.

36.

Production of enterotoxin A and thermonuclease by Staphylococcus aureus in legumes.

Neumayr L, Krämer J.

Int J Food Microbiol. 1990 May;10(3-4):225-33.

PMID:
2397154

Supplemental Content

Loading ...
Support Center